Issue Information.
- Published in:
- Clinical Pharmacology in Drug Development, 2023, v. 12, n. 9, p. 845, doi. 10.1002/cpdd.981
- Publication type:
- Article
Works matching IS 2160763X AND DT 2023 AND VI 12 AND IP 9
Results: 11
1
2
Pharmacokinetics of the Akt Serine/Threonine Protein Kinase Inhibitor, Capivasertib, Administered to Healthy Volunteers in the Presence and Absence of the CYP3A4 Inhibitor Itraconazole.
- Published in:
- Clinical Pharmacology in Drug Development, 2023, v. 12, n. 9, p. 856, doi. 10.1002/cpdd.1307
- By:
- Publication type:
- Article
3
Concentration–QTc Relationship from a Single Ascending Dose Study of ANAVEX3‐71, a Novel Sigma‐1 Receptor and Allosteric M1 Muscarinic Receptor Agonist in Development for the Treatment of Frontotemporal Dementia, Schizophrenia, and Alzheimer's Disease
- Published in:
- Clinical Pharmacology in Drug Development, 2023, v. 12, n. 9, p. 888, doi. 10.1002/cpdd.1303
- By:
- Publication type:
- Article
4
Pharmacokinetic Similarity of ABP 654, an Ustekinumab Biosimilar Candidate: Results from a Randomized, Double‐blind Study in Healthy Subjects.
- Published in:
- Clinical Pharmacology in Drug Development, 2023, v. 12, n. 9, p. 863, doi. 10.1002/cpdd.1301
- By:
- Publication type:
- Article
5
Current Status of Weekly Insulin Analogs and Their Pharmacokinetic/Pharmacodynamic Evaluation by the Euglycemic Clamp Technique.
- Published in:
- Clinical Pharmacology in Drug Development, 2023, v. 12, n. 9, p. 849, doi. 10.1002/cpdd.1296
- By:
- Publication type:
- Article
6
Evaluation of the Mass Balance and Metabolic Profile of Futibatinib in Healthy Participants.
- Published in:
- Clinical Pharmacology in Drug Development, 2023, v. 12, n. 9, p. 927, doi. 10.1002/cpdd.1271
- By:
- Publication type:
- Article
7
Pharmacokinetic Drug‐Drug Interaction With Coadministration of Cannabidiol and Everolimus in a Phase 1 Healthy Volunteer Trial.
- Published in:
- Clinical Pharmacology in Drug Development, 2023, v. 12, n. 9, p. 911, doi. 10.1002/cpdd.1262
- By:
- Publication type:
- Article
8
Pharmacokinetics, Bioequivalence, and Safety Evaluation of 2 Formulations of 10‐mg Rivaroxaban Tablets: A 4‐Period Crossover Trial.
- Published in:
- Clinical Pharmacology in Drug Development, 2023, v. 12, n. 9, p. 920, doi. 10.1002/cpdd.1261
- By:
- Publication type:
- Article
9
Pharmacokinetics and Pharmacodynamics of Lansoprazole/Sodium Bicarbonate Immediate‐release Capsules in Healthy Chinese Subjects: An Open, Randomized, Controlled, Crossover, Single‐, and Multiple‐dose Trial.
- Published in:
- Clinical Pharmacology in Drug Development, 2023, v. 12, n. 9, p. 902, doi. 10.1002/cpdd.1251
- By:
- Publication type:
- Article
10
Comparative Pharmacokinetics and Safety Studies of Dexibuprofen Injection and a Branded Product Ibuprofen Injection in Healthy Chinese Volunteers.
- Published in:
- Clinical Pharmacology in Drug Development, 2023, v. 12, n. 9, p. 881, doi. 10.1002/cpdd.1260
- By:
- Publication type:
- Article
11
Bioequivalence Study of Two Formulations of Mifepristone Tablets in Healthy Chinese Subjects Under Fasting Conditions.
- Published in:
- Clinical Pharmacology in Drug Development, 2023, v. 12, n. 9, p. 874, doi. 10.1002/cpdd.1249
- By:
- Publication type:
- Article